GBS-NN2 (Minervax)

N/A

Report date: 2024/07/11 20:00:08

Base Information

Drug NameGBS-NN2 (Minervax)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitisNeonatal SepsisPneumonia +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUgandaSouth Africa +[5] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMinervax Aps
China Registration ClassN/A

Develop Information

Active CompaniesMinervax Aps
Inactive CompaniesN/A
Active IndicationsMeningitisNeonatal SepsisPneumonia +[7] 
Inactive IndicationsInfections

Other Information

ATC CodeN/A
Related LinksN/A